LEADER 05262nam 2200709Ia 450 001 9911019983503321 005 20200520144314.0 010 $a9786612684951 010 $a9781282684959 010 $a1282684957 010 $a9781444300857 010 $a1444300857 010 $a9781444300864 010 $a1444300865 035 $a(CKB)1000000000715955 035 $a(EBL)416411 035 $a(SSID)ssj0000151282 035 $a(PQKBManifestationID)11159020 035 $a(PQKBTitleCode)TC0000151282 035 $a(PQKBWorkID)10282210 035 $a(PQKB)11294760 035 $a(MiAaPQ)EBC416411 035 $a(OCoLC)352789900 035 $a(PPN)175875618 035 $a(Perlego)2759525 035 $a(EXLCZ)991000000000715955 100 $a20071115d2008 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aEvidence-based hematology /$fedited by Mark A. Crowther ... [et al.] 210 $aChichester, UK ;$aHoboken, NJ $cWiley-Blackwell$d2008 215 $a1 online resource (440 p.) 225 1 $aEvidence-Based Medicine 300 $aDescription based upon print version of record. 311 08$a9781405157476 311 08$a140515747X 320 $aIncludes bibliographical references and index. 327 $aContents; List of Contributors; Preface; Part 1 A Guide to the Evidence; 1 Rating the Quality of Evidence and Making Recommendations; 2 An Overview of Systematic Reviews; 3 Interpreting Results in Clinical Research; 4 Finding the Evidence in Hematology; 5 Applying EBM in Clinical Practice; 6 Using Evidence to Guide the Diagnosis of Disease; Part 2 Hemostasis and Thrombosis; 7 Diagnosis of Deep Vein Thrombosis; 8 The Diagnosis of Acute Pulmonary Embolism; 9 Initial Therapy of Deep Vein Thrombosis and Pulmonary Embolism; 10 Long-Term Anticoagulation in Venous Thromboembolism 327 $a11 Thrombolytic Therapy for Deep Vein Thrombosis and Pulmonary Embolism12 Inferior Vena Cava Interruption; 13 Management of Venous Thromboembolism in Pregnancy; 14 Pediatric Thrombosis; 15 Bridging Anticoagulation in Patients Who Require Temporary Interruption of Warfarin for Surgery; 16 Evidence-based Approach to the Diagnosis and Management of Thrombotic Thrombocytopenic Purpura; 17 Diagnosis and Management of Disseminated Intravascular Coagulation; 18 Diagnosis and Management of Hereditary Bleeding Disorders; 19 Diagnosis and Management of Acquired Bleeding Disorders 327 $a20 Diagnosis and Management of Heparin-Induced Thrombocytopenia21 Management of Antiphospholipid Antibody Syndrome; Part 3 Benign Hematologic Disorders; 22 Clinical Questions in Iron Overload; 23 Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, and Pure Red Cell Aplasia; 24 Acquired Anemias; 25 Immune Thrombocytopenic Purpura; 26 Neutropenia; 27 Hypereosinophilia; 28 Porphyrias; 29 Membrane and Enzyme Abnormalities of the Erythrocyte; 30 Sickle Cell Disease; 31 Evidence-based Treatment of Thalassemia Major; Part 4 Malignant Hematologic Disorders; 32 Acute Lymphoblastic Leukemia in Adults 327 $a33 Acute Myeloid Leukemia in Adults34 Acute Myeloid Leukemia in Adults; 35 Current Areas of Controversy in the Treatment of Patients With Newly Diagnosed Acute Promyelocytic Leukemia; 36 Chronic Lymphocytic Leukemia; 37 Chronic Myeloid Leukemia; 38 Selected Management of Patients with Myelodysplastic Syndromes; 39 Evidence-based Treatment of Burkitt Lymphoma in Adults; 40 Primary Central Nervous System Lymphoma; 41 Diffuse Large B-cell Lymphoma; 42 Follicular Lymphoma; 43 Lymphoblastic Lymphoma; 44 Mantle Cell Lymphoma; 45 Management of Patients with Peripheral T-cell Lymphoma 327 $a46 Selected Management Issues of Patients with Hodgkin Lymphoma47 Lymphocyte Predominant Hodgkin Lymphoma; 48 Management of Patients with Essential Thrombocythemia; 49 Management of Patients with Polycythemia Vera; 50 Evidence-based Review of Therapies in Multiple Myeloma; 51 Management of Waldenstrom's Macroglobulinemia; 52 The Role of Hematopoietic Growth Factors in Managing Patients with Hematologic Malignancies; Index 330 $aThis unique new book uses a series of focussed questions, comprehensive literature evaluations and structured grades of recommendation to provide evidence for the treatment of hematological disorders, both malignant and benign. With contributions from leading international experts who have a real understanding of evidence-based medicine the book provides comprehensive reviews accompanied by clinical commentaries and recommendations on the best treatment regimes to adopt for individual patients.The book is split into two sections: the first examines the methodology underlying evidence b 410 0$aEvidence-Based Medicine 606 $aBlood$xDiseases 606 $aHematology 606 $aEvidence-based medicine 615 0$aBlood$xDiseases. 615 0$aHematology. 615 0$aEvidence-based medicine. 676 $a616.1/5 701 $aCrowther$b Mark$f1966-$01838225 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9911019983503321 996 $aEvidence-based hematology$94417167 997 $aUNINA